Company Filing History:
4 out of 4 
1 out of 388 
1 out of 15,475 
Years Active: 2017-2023
Title: Innovations of Inventor Xinmin Xie
Introduction
Xinmin Xie is a prominent inventor based in Burlingame, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of ion channel inhibitory compounds. With a total of four patents to her name, her work focuses on addressing various neurological and psychiatric disorders.
Latest Patents
Xinmin Xie's latest patents include innovative methods for treating hypersensitive cough or itching using ion channel inhibitory compounds. The first patent is directed towards new chemical entities that primarily inhibit human T-type calcium channels. These compounds are designed to differentially modulate other key ion channels to control cell excitability and abnormal neuronal activity, particularly in cases of hypersensitive cough or itching. The second patent also involves ion channel inhibitory compounds and pharmaceutical formulations aimed at controlling cell excitability and addressing persistent or chronic pain, as well as neurological disorders. These novel compounds are essential for the treatment and prevention of various conditions where these ion channels play a critical role.
Career Highlights
Throughout her career, Xinmin Xie has worked with notable organizations, including Afasci, Inc. and the Kansas State University Research Foundation. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Xinmin has collaborated with esteemed colleagues such as Frank Kayser and Conrado Pascual. These partnerships have further enriched her research endeavors and have led to the development of groundbreaking innovations in her field.
Conclusion
In summary, Xinmin Xie is a trailblazing inventor whose work in ion channel inhibitory compounds has the potential to transform the treatment of neurological and psychiatric disorders. Her contributions to science and medicine are invaluable, and her patents reflect her dedication to improving patient outcomes.